Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Summary: Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate addictive behaviours and nicotine craving. Previo...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Hualin Lüthi, Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, Nica Jeanloz, Tanja Vukajlovic, Katja Bologna, Michelle Steinmetz, Cemile Bathelt, Clara O. Sailer, Mirjam Laager, Deborah R. Vogt, Lars G. Hemkens, Benjamin Speich, Sandrine A. Urwyler, Jill Kühne, Fabienne Baur, Linda N. Lutz, Tobias E. Erlanger, Mirjam Christ-Crain, Bettina Winzeler
פורמט: Article
שפה:English
יצא לאור: Elsevier 2024-02-01
סדרה:EClinicalMedicine
נושאים:
Glucagon-like peptide-1 (GLP-1) analogues
Quitting smoking
Long-term abstinence
Post-cessation weight gain
גישה מקוונת:http://www.sciencedirect.com/science/article/pii/S2589537024000087

אינטרנט

http://www.sciencedirect.com/science/article/pii/S2589537024000087

פריטים דומים